MedTrace Logo

Microbial Associations in Periodontal Health and Disease

NCT00066001 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2010-11-09

No results posted yet for this study

Summary

The purpose of this study is to determine the clinical and microbiological effects of systemically administered metronidazole alone or in combination with professional plaque removal on periodontally diseased patients.

Conditions

  • Periodontitis
  • Periodontal Diseases

Interventions

DRUG

metronidazole

antibiotic that is particularly effective against Gram negative bacterial species

Sponsors & Collaborators

  • National Institute of Dental and Craniofacial Research (NIDCR)

    collaborator NIH

  • The Forsyth Institute

    lead OTHER

Principal Investigators

  • Ann Haffajee · Boston, MA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-12-31
Primary Completion
2007-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00066001 on ClinicalTrials.gov